doi: 10.1007/s10753-020-01233-w 168 LinC.-Y.YaoC.-A
Wang, X., Chen, L., Zhang, C., Shi, Q., Zhu, L., Zhao, S., Luo, Z., & Long, Y
However, some studies show that semaglutide (the active ingredient in Wegovy) may actually lower the risk of anxiety, especially in people with diabetes
Discuss contraception options with your healthcare provider, as additional contraception is needed for 4 weeks after starting treatment and after each dose increase, or non-oral methods should be considered
Your provider may also recommend an abdominal assessment if you have a history of gallbladder issues or pancreatitis, as these are relevant safety considerations for GLP-1 therapy